{"page_content": "About           +           Serve           +           Transform           +           Advance           +           Redefine           +           Ethics & Compliance                      Reporting Index           \nBRIGHTER FUTURES  |  2019 CSR Report53\nDISCLOSURE TITLE EXPLANATION or LOCATION\nGeneral Disclosures\n102-1 Name of the organization Alexion Pharmaceuticals, Inc. \n102-2Activities, brands, products, and \nservicesAlexion 2019 Form 10-K, Item 1 (Business: Overview, Products and Development Programs)\nAlexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our \nStakeholders, Page 7\n102-3 Location of headquarters Boston, Massachusetts, United States \n102-4 Location of operationsAlexion 2019 Form 10-K, Item 1 (Business: Manufacturing, Sales and Marketing); Item 2 \n(Properties)\nAlexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our \nStakeholders, Page 8 (Primary Locations)\n102-5 Ownership and legal formAlexion\u2019s common stock is quoted on The Nasdaq Stock Market, LLC under the symbol \n\u201cALXN.\u201d\n102-6 Markets served Alexion 2019 Form 10-K, Item 1 (Business: Customers); Note 19 (Segment Information)\n102-7 Scale of the organizationAlexion 2019 Form 10-K, Item 1 (Business: Products and Development Programs, Employees); Item 2 (Properties); Item 6 (Selected Financial Data)\nAlexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our \nStakeholders, Page 8 (Company Snapshot)\n102-8Information on employees and other \nworkersAlexion 2019 Form 10-K, Item 1 (Business: Employees)\nAlexion 2019 CSR Report, About Alexion: Working Toward Brighter Futures for All of Our \nStakeholders, Page 8 (Company Snapshot)GRI INDEX", "metadata": {"source": "NASDAQ_ALXN_2019.pdf", "page": 52, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}